TY - JOUR
T1 - Breakdown of immune tolerance in AIRE-deficient rats induces a severe autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy-like autoimmune disease
AU - Ossart, Jason
AU - Moreau, Anne
AU - Autrusseau, Elodie
AU - Ménoret, Séverine
AU - Martin, Jérôme C.
AU - Besnard, Marine
AU - Ouisse, Laure Hélène
AU - Tesson, Laurent
AU - Flippe, Léa
AU - Kisand, Kai
AU - Peterson, Pärt
AU - Hubert, François Xavier
AU - Anegon, Ignacio
AU - Josien, Régis
AU - Guillonneau, Carole
N1 - Funding Information:
This work was supported by the National Research Agency, in the context of the Laboratoire d'Excellence Immunotherapy Graft Oncology program, via the investment of future program Contract ANR-11-LABX-0016-01 and under the auspices of the Institut Hospitalo-Universitaire-Centre Européen des Sciences de Transplantation et Immunothérapie (IHU-CESTI) project, which received French government financial support managed by the National Research Agency (ANR) via the investment of future program Contract ANR-10-IBHU-005. The IHU-CESTI project is also supported by Nantes Metropole and the Pays de la Loire Region. This work was also performed in the context of the Transgenèse pour les Etudes Fonctionnelles sur les Organismes Modèles project funded by the Investissements d'Avenir French Government program, managed by the ANR (Contract ANRII-INSB-0014). The study was also supported by Estonian Research Agency (Contract IUT2-2). For this work, J.O. was supported by Fondation pour la Recherche Médicale Contract PLP20141031245, and F.-X.H. was supported by a Marie Curie Outgoing Fellowship from the Framework Program 6. The Fondation Progreffe also provided financial support.
Funding Information:
The study was also supported by Estonian Research Agency (Contract IUT2-2). For this work, J.O. was supported by Fondation pour la Recherche Médicale Contract PLP20141031245, and F.-X.H. was supported by a Marie Curie Outgoing Fellowship from the Framework Program 6. The Fondation Progreffe also provided financial support.
Funding Information:
This work was supported by the National Research Agency, in the context of the Laboratoire d’Excellence Immunotherapy Graft Oncology program, via the investment of future program Contract ANR-11-LABX-0016-01 and under the auspices of the Institut Hospitalo-Universitaire–Centre Européen des Sciences de Transplantation et Immunothérapie (IHU-CESTI) project, which received French government financial support managed by the National Research Agency (ANR) via the investment of future program Contract ANR-10-IBHU-005. The IHU-CESTI project is also supported by Nantes Metropole and the Pays de la Loire Region. This work was also performed in the context of the Transgenèse pour les Etudes Fonctionnelles sur les Organismes Modèles project funded by the Investissements d’Avenir French Government program, managed by the ANR (Contract ANRII-INSB-0014).
Publisher Copyright:
© 2018 American Association of Immunologists. All rights reserved.
PY - 2018/8/1
Y1 - 2018/8/1
N2 - Autoimmune regulator (AIRE) deficiency in humans induces a life-threatening generalized autoimmune disease called autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED), and no curative treatments are available. Several models of AIRE-deficient mice have been generated, and although they have been useful in understanding the role of AIRE in central tolerance, they do not reproduce accurately the APECED symptoms, and thus there is still a need for an animal model displaying APECED-like disease. We assessed, in this study, the potential of the rat as an accurate model for APECED. In this study, we demonstrate that in rat, AIRE is expressed by MHC class II (MCH-II)+ and MHC-II2 medullary thymic epithelial cells in thymus and by CD4int conventional dendritic cells in periphery. To our knowledge, we generated the first AIRE-deficient rat model using zinc-finger nucleases and demonstrated that they display several of the key symptoms of APECED disease, including alopecia, skin depigmentation, and nail dystrophy, independently of the genetic background. We observed severe autoimmune lesions in a large spectrum of organs, in particular in the pancreas, and identified several autoantibodies in organs and cytokines such as type I IFNs and IL-17 at levels similar to APECED. Finally, we demonstrated a biased Ab response to IgG1, IgM, and IgA isotypes. Altogether, our data demonstrate that AIRE-deficient rat is a relevant APECED animal model, opening new opportunity to test curative therapeutic treatments.
AB - Autoimmune regulator (AIRE) deficiency in humans induces a life-threatening generalized autoimmune disease called autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED), and no curative treatments are available. Several models of AIRE-deficient mice have been generated, and although they have been useful in understanding the role of AIRE in central tolerance, they do not reproduce accurately the APECED symptoms, and thus there is still a need for an animal model displaying APECED-like disease. We assessed, in this study, the potential of the rat as an accurate model for APECED. In this study, we demonstrate that in rat, AIRE is expressed by MHC class II (MCH-II)+ and MHC-II2 medullary thymic epithelial cells in thymus and by CD4int conventional dendritic cells in periphery. To our knowledge, we generated the first AIRE-deficient rat model using zinc-finger nucleases and demonstrated that they display several of the key symptoms of APECED disease, including alopecia, skin depigmentation, and nail dystrophy, independently of the genetic background. We observed severe autoimmune lesions in a large spectrum of organs, in particular in the pancreas, and identified several autoantibodies in organs and cytokines such as type I IFNs and IL-17 at levels similar to APECED. Finally, we demonstrated a biased Ab response to IgG1, IgM, and IgA isotypes. Altogether, our data demonstrate that AIRE-deficient rat is a relevant APECED animal model, opening new opportunity to test curative therapeutic treatments.
UR - https://www.scopus.com/pages/publications/85050752343
U2 - 10.4049/jimmunol.1701318
DO - 10.4049/jimmunol.1701318
M3 - Article
C2 - 29959280
AN - SCOPUS:85050752343
SN - 0022-1767
VL - 201
SP - 874
EP - 887
JO - Journal of Immunology
JF - Journal of Immunology
IS - 3
ER -